<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04294355</url>
  </required_header>
  <id_info>
    <org_study_id>UW 19-713</org_study_id>
    <nct_id>NCT04294355</nct_id>
  </id_info>
  <brief_title>AI-assisted Colonoscopy on Detection of Missed Proximal Lesions</brief_title>
  <official_title>Artificial Intelligence-assisted Colonoscopy Versus Conventional Colonoscopy for Missed Lesions in the Proximal Colon: A Prospective Multi-center Randomized Study in Asia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tan Tock Seng Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The University of Hong Kong-Shenzhen Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chongqing University Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hanoi Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Hong Kong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective multi-center randomized study is to determine whether the use of
      AI-assistance could reduce the miss rates of polyps and adenomas in the proximal colon during
      tandem examination
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Centers

        1. Queen Mary Hospital, Hong Kong, China (Co-ordinating Center)

        2. Tan Tock Seng Hospital, Singapore, Singapore

        3. HKU Shenzhen Hospital, Shenzhen, China

        4. ChongQing University Cancer Hospital, Chongqing, China

        5. Institute of Gastroenterology and Hepatology, Vietnam Union of Science and Technology
           Association, Hanoi, Vietnam

      Study population

      Inclusion:

      All adult patients, aged 40 or above, undergoing outpatient colonoscopy in the participating
      centers will be recruited.

      Exclusion:

        -  history of inflammatory bowel disease

        -  history of colorectal cancer

        -  previous bowel resection (apart from appendectomy)

        -  Peutz-Jeghers syndrome, familial adenomatous polyposis or other polyposis syndromes

        -  bleeding tendency or severe comorbid illnesses for which polypectomy is considered
           unsafe.

      Post-randomization exclusion:

        -  Cecum could not be intubated for various reasons

        -  Boston Bowel Preparation Scale (BBPS) score of the proximal colon is &lt;2

      Study design This is a prospective randomized trial comparing the miss rates of proximal
      colonic lesions by AI assisted colonoscopy or conventional colonoscopy (Fig. 1). The study
      will be conducted in the Endoscopy Centre of the participating hospitals.

      Randomization Eligible patients in each center will be randomly allocated in a 1:1 ratio to
      undergo tandem colonoscopy of the proximal colon first with AI-assistance and follow by
      conventional white light colonoscopy (Group 1) or conventional white light colonoscopy
      without AI assistance follow by conventional colonoscopy (Group 2). Proximal colon refers to
      colonic segement proximal to the splenic flexure. Randomization will be conducted in blocks
      of 4 by computer generated random sequences and stratified according to indications of
      colonoscopy (symptomatic vs screening/surveillance). Patients will be blinded to the group
      assignment.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2020</start_date>
  <completion_date type="Anticipated">July 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective randomized design</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proximal adenoma missed rate</measure>
    <time_frame>One day</time_frame>
    <description>The proportion of patients with missed adenomas detected in the second examination only</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proximal polyp missed rate</measure>
    <time_frame>One day</time_frame>
    <description>The proportion of patients with missed adenomas detected in the second examination only</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proximal adenoma detection rate</measure>
    <time_frame>One day</time_frame>
    <description>The proportion of patients with at least one adenoma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proximal polyp detection</measure>
    <time_frame>One day</time_frame>
    <description>The proportion of patients with at least one polyp</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Colon Adenoma</condition>
  <condition>Colon Polyp</condition>
  <arm_group>
    <arm_group_label>Artificial intelligence-Assisted colonoscopy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tandem colonoscopy of proximal colon assisted with artificial intelligence followed by conventional colonoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional colonoscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Tandem conventional colonoscopy of proximal colon followed by usual conventional colonoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Artificial intelligence-Assisted colonoscopy</intervention_name>
    <description>Artificial intelligence-Assisted colonoscopy for detection of colonic polyp</description>
    <arm_group_label>Artificial intelligence-Assisted colonoscopy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional colonoscopy</intervention_name>
    <description>Conventional colonoscopy</description>
    <arm_group_label>Artificial intelligence-Assisted colonoscopy</arm_group_label>
    <arm_group_label>Conventional colonoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All adult patients, aged 40 or above, undergoing outpatient colonoscopy in the
             participating centers will be recruited

        Exclusion Criteria:

          -  history of inflammatory bowel disease

          -  history of colorectal cancer

          -  previous bowel resection (apart from appendicetomy)

          -  Peutz-Jeghers syndrome, familial adenomatous polyposis or other polyposis syndromes

          -  bleeding tendency or severe comorbid illnesses for which polypectomy is considered
             unsafe.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ka Luen, Thomas Lui, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Queen Mary Hospital, the University of Hong Kong</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wai Keung Leung, MD</last_name>
    <role>Study Director</role>
    <affiliation>Queen Mary Hospital, the University of Hong Kong</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ka Luen, Thomas Lui, MBBS</last_name>
    <phone>85222554048</phone>
    <email>luikaluen@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wai Keung Leung, MD</last_name>
    <phone>85222553348</phone>
    <email>waikleung@hku.hk</email>
  </overall_contact_backup>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 2, 2020</study_first_submitted>
  <study_first_submitted_qc>March 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 4, 2020</study_first_posted>
  <last_update_submitted>March 3, 2020</last_update_submitted>
  <last_update_submitted_qc>March 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Colonoscopy</keyword>
  <keyword>Artificial intelligence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

